A director of Asia-focused investment company Symphony International Holdings continued to ramp up his investment in the company on Friday, purchasing a further $200,000 of shares.
Checkit revealed on Thursday that chief executive Kit Kyte had acquired 618,745 ordinary shares in the AIM-listed automated monitoring platform operator.
Sysgroup revealed on Wednesday that non-executive director Michael Fletcher had acquired 77,623 ordinary shares in the AIM-listed managed technology partner.
Midwich revealed on Tuesday that chief financial officer Adam Councell had acquired 74,586 ordinary shares in the AIM-listed technology solutions provider.
Sirius Real Estate revealed on Monday that chief executive Andrew Coombs had acquired 100,000 ordinary shares in the FTSE 250-listed property firm.
Trufin revealed on Friday that chief executive James van den Bergh had acquired 25,000 ordinary shares in the AIM-listed software firm.
The largest market purchase of shares in London on Thursday came from Oxford Biomedica's chair Roch Doliveux. who upped his stake in the cell and gene therapy company after a sharp drop in the stock over the year to date.
Intercede Group revealed on Wednesday that non-executive director Dan O'Brien had acquired 22,070 ordinary shares in the AIM-listed cybersecurity software firm.
Forterra revealed on Tuesday that non-executive director Gavin Hill had acquired 28,944 ordinary shares in the London-listed building products manufacturer.
Trufin revealed on Monday that chief executive James van den Bergh had acquired 150,000 ordinary shares in the AIM-listed software firm.
Astrazeneca revealed on Friday that chief executive Pascal Soriot had acquired 60,000 ordinary shares in the FTSE 100-listed drugmaker.
McBride said on Thursday that chief financial officer Marck Strickland had disposed of 110,000 ordinary shares in the London-listed household goods manufacturer.
Hilton Food Group revealed on Wednesday that chief executive Mark Allen had acquired 14,500 ordinary shares in the FTSE 250-listed food packaging business.
Kromek Group revealed on Tuesday that chairman Rakesh Sharma had acquired 145,454 ordinary shares in the AIM-listed global detection firm.
Fevertree Drinks revealed on Monday that chairman Domenic De Lorenzo had acquired 44,674 ordinary shares in the AIM-listed non-alcholic drinksmaker.
Two board members of Applied Nutrition have sold nearly £20m of shares in the sports supplements manufacturer, the company revealed on Friday, as part of the first placing since its 2024 IPO.
Dunelm revealed on Thursday that chairwoman Alison Brittain had acquired 10,000 ordinary shares in the FTSE 250-listed homewares retailer.
Rosebank Industries revealed on Wednesday that senior independent director Christopher Miller had acquired 414,803 ordinary shares in the FTSE 250-listed industrial company.
Cloudcoco Group revealed on Tuesday that chairman Simon Duckworth had acquired 5m ordinary shares in the AIM-listed e-commerce and IT procurement group.
Sirius Real Estate revealed on Monday that non-executive director Joanne Kenrick had acquired 31,699 ordinary shares in the FTSE 250-listed real estate investment trust.
